CN1266681A - Carbocisteine composition for promoting healing of wound and burn - Google Patents
Carbocisteine composition for promoting healing of wound and burn Download PDFInfo
- Publication number
- CN1266681A CN1266681A CN 00103487 CN00103487A CN1266681A CN 1266681 A CN1266681 A CN 1266681A CN 00103487 CN00103487 CN 00103487 CN 00103487 A CN00103487 A CN 00103487A CN 1266681 A CN1266681 A CN 1266681A
- Authority
- CN
- China
- Prior art keywords
- carbocisteine
- wound
- burn
- compositions
- healing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A carbocisteine composition for promoting healing of wound and burn is prepared from carbocisteine, sodium citrate, sodium laurylsulfate, magnesium laurylsulfate and sodium deoxychloate through mixing, heating, stirring, cooling, grinding, mixing and stirring. It can be combined with any medicinal carrier for wound, quickly stabilize the wound and burn and make them healing, and reduce the scar generation. It can also be used for skin transplating.
Description
The present invention relates to the carbocisteine compositions of a kind of acceleration of wound and burn-healing, relate to specifically a kind ofly be prepared from by carbocisteine and cell induction agent, can stablize wound and burn rapidly, quicken the compositions of its healing, have another name called compositions for Carbocisteine.
At present, wound and burn are a kind of common disease of surgery medical science on clinical medicine.The generally acknowledging principle that its wound surface is handled is: remove slough, the protection wound surface is protected from infection, and promotes epithelial cell growth.Yet prior treatment method still rests on the outmoded level of anti-inflammation, generally is to adopt silver sulfadiazine, to keep the wound surface drying, protects from infection.This medicine can not prevent the pathological change (body fluid oozes out, and nutritional labeling is lost, the evaporation of heat etc.) of burn wound, can not promote epithelial cell growth effectively.Certain anti-infectious function can only be played, the situation of traumatic infection can not be eliminated and thoroughly change fully.Moreover the existing antibacterial-anti-inflammatory drug that is used for wound and burn can not play to be accelerated wound healing and shortens the wound time, so how could stablize wound and burn rapidly, quickening its healing is the focus that the relevant person pays close attention to.
The object of the present invention is to provide a kind ofly to be prepared from, can stablize wound and burn rapidly, shorten the acceleration of wound of wound time and the carbocisteine compositions of burn-healing by carbocisteine and cell induction agent.
The object of the present invention is achieved like this: it is made up of carbocisteine and cell induction agent sodium citrate, sodium lauryl sulphate, Stepanol MG, NaTDC, form through grinding, sieve, mix, stirring, it is characterized in that it is the compositions of being made by following weight (g) proportion raw material:
Carbocisteine 0.1-8.0
Sodium citrate 1.0-5.0
Sodium lauryl sulphate 1.0-3.0
Stepanol MG 1.0-3.0
NaTDC 1.0-3.0.
Its feature is that also it is the compositions of preferred following weight (g) proportion raw material preparation:
Carbocisteine 1.5
Sodium citrate 1.0-5.0
Sodium lauryl sulphate 1.5
Stepanol MG 1.0-3.0
NaTDC 1.0-3.0.
Its feature also is: the granule of described carbocisteine≤70 micron.
Its feature also is: described cell induction agent is sodium citrate, sodium lauryl sulphate, Stepanol MG and NaTDC, but also wherein one or more.
The present invention compared with prior art, it can combine with any pharmaceutical carrier that can be applicable to wound in this area, can stablize wound and burn rapidly, effectively shorten the wound time, impel wound and burn normal healing rapidly, reduce the scar hyperplasia rate, the transplanting that it also can be used for skin strengthens the one-tenth activity of transplanted thing destination locations in host's bed.
Embodiment one
Abdominal part is scalded dark II degree wound surface, adopts general wound Drug therapy, around be the course of treatment; Select for use the present invention by 70 micron granularity carbocisteine 1.5g, with the cell induction agent: the compositions that sodium citrate 1.0g, sodium lauryl sulphate 1.5g, Stepanol MG 1.5g, NaTDC 1.5g become through conventional method processing and preparing such as grinding, mixing, stirrings, have another name called compositions for Carbocisteine, on spreading and the wound face, contact processing, two weeks can heal, and had significantly shortened the wound time, had alleviated patient's misery.
Embodiment two
Diabetes finger tip ulcer adopts general medicine for ulcer treatment, needs for 15 weeks the course of treatment; Select for use the present invention by 70 micron granularity carbocisteine 1.5g, with the cell induction agent: the compositions that sodium citrate 0.8g, sodium lauryl sulphate 1.5g, Stepanol MG 1.6g, NaTDC 1.3g become through conventional method processing and preparing such as grinding, mixing, stirrings, have another name called compositions for Carbocisteine, on spreading and the wound face, contact processing, ten weeks can heal, and had significantly shortened the wound time, had alleviated patient's misery.
Claims (4)
1, the carbocisteine compositions of a kind of acceleration of wound and burn-healing, it is made up of carbocisteine, sodium citrate, sodium lauryl sulphate, Stepanol MG and NaTDC, stir and form through mixing, heating, stirring, cooling, grinding, remix, it is characterized in that it is the compositions of being made by following weight (g) proportion raw material:
Carbocisteine 0.1-8.0
Sodium citrate 1.0-5.0
Sodium lauryl sulphate 1.0-3.0
Stepanol MG 1.0-3.0
NaTDC 1.0-3.0.
2, the carbocisteine compositions of acceleration of wound according to claim 1 and burn-healing, its feature are that also it is the compositions of preferred following weight (g) proportion raw material preparation:
Carbocisteine 1.5
Sodium citrate 1.0-5.0
Sodium lauryl sulphate 1.5
Stepanol MG 1.0-3.0
NaTDC 1.0-3.0.
3, the carbocisteine compositions of acceleration of wound according to claim 1 and burn-healing, its feature also is: the granule of described carbocisteine≤70 micron.
4, the carbocisteine compositions of acceleration of wound according to claim 1 and burn-healing, its feature also is: described cell induction agent is sodium citrate, sodium lauryl sulphate, Stepanol MG and NaTDC, but also wherein one or more.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001034871A CN1139379C (en) | 2000-03-15 | 2000-03-15 | Carbocisteine composition for promoting healing of wound and burn |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001034871A CN1139379C (en) | 2000-03-15 | 2000-03-15 | Carbocisteine composition for promoting healing of wound and burn |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1266681A true CN1266681A (en) | 2000-09-20 |
| CN1139379C CN1139379C (en) | 2004-02-25 |
Family
ID=4577022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001034871A Expired - Fee Related CN1139379C (en) | 2000-03-15 | 2000-03-15 | Carbocisteine composition for promoting healing of wound and burn |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1139379C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3081212A1 (en) * | 2015-04-16 | 2016-10-19 | Polichem SA | Carboxymethylcysteine for topical treatment of stretch marks |
| CN114366731A (en) * | 2022-02-10 | 2022-04-19 | 王有仁 | Application of carboxymethyl cysteine crystal in preparation of enzyme activity activator |
| WO2023126161A1 (en) * | 2021-12-31 | 2023-07-06 | Unilever Ip Holdings B.V. | A personal care or pharmaceutical composition |
-
2000
- 2000-03-15 CN CNB001034871A patent/CN1139379C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3081212A1 (en) * | 2015-04-16 | 2016-10-19 | Polichem SA | Carboxymethylcysteine for topical treatment of stretch marks |
| WO2016166082A1 (en) | 2015-04-16 | 2016-10-20 | Polichem S.A. | Carboxymethylcysteine for topical treatment of stretch marks |
| WO2023126161A1 (en) * | 2021-12-31 | 2023-07-06 | Unilever Ip Holdings B.V. | A personal care or pharmaceutical composition |
| CN114366731A (en) * | 2022-02-10 | 2022-04-19 | 王有仁 | Application of carboxymethyl cysteine crystal in preparation of enzyme activity activator |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1139379C (en) | 2004-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Smets et al. | Non-surgical treatment of condylar fractures in adults: a retrospective analysis | |
| Couch et al. | Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy | |
| WO2015096271A1 (en) | High strength and toughness corrosion-resistant zinc alloy inplant material capable of being absorbed by human body | |
| Hooley et al. | The effect of polylactic acid granules on the incidence of alveolar osteitis after mandibular third molar surgery: A prospective randomized study | |
| CN1145031A (en) | Starch-metal complexes for skin and hair | |
| Chuchurru et al. | Myxoma of the mandible with unusual radiographic appearance | |
| CN1139379C (en) | Carbocisteine composition for promoting healing of wound and burn | |
| CN108578540A (en) | A kind of biologic formulation and preparation method thereof for inhibiting scar and promoting wound healing | |
| CN100363016C (en) | Compound Chinese medicine prepn for fast healing trauma and its preparing method | |
| Kumar et al. | Collagen membrane: A new concept in surgical management for mucosal defect in oral sub mucous fibrosis. | |
| CN102631373A (en) | Medicine chewing gum for rapidly treating oral ulcer | |
| CN106562953B (en) | Application, drug and process for preparing medicine of the hydroxyl radical carthamin yellow carthamus A in the drug of preparation treatment diabetic foot ulcer | |
| CN102028875B (en) | Medicament for treating open wound and preparation method thereof | |
| CN1256112C (en) | Chinese traditional medicine preparation for treating cardiac and cerebral vascular diseases and its preparation process | |
| Thorn et al. | Arterial embolisation in the treatment of central haemangiomas of the maxilla. Report of two cases | |
| Melamed et al. | Anterior Ankle Full Thickness Skin Necrosis Treated with Copper Oxide Dressings without Debridement and Skin Grafting–A Case Report | |
| CN100411650C (en) | A compound capsule for treating Bi syndrome | |
| CN109536778A (en) | A kind of medical degradable zinc bismuth lithium system alloy | |
| RU2137492C1 (en) | Renal species | |
| CN108392572A (en) | A kind of plaster and its preparation method and application that expelling the stasis for the new sore relieves the pain | |
| CN1176685C (en) | Medicine for preventing and treating coronary heart disease and its prepn process | |
| RU2119756C1 (en) | Hematogen | |
| CN1044778C (en) | Suppurative wound treating medicine for domestic animal | |
| KR100584214B1 (en) | The method of manufacturing potentiator using oyster shell powder | |
| CN1075383C (en) | Bone-setting and muscle-jointing-up medicine and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Youren Document name: Notification to Pay the Fees |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Youren Document name: Notification of Termination of Patent Right |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040225 Termination date: 20180315 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |